Dr Elliot Parks | President & CEO
Hawaii Biotech

Dr Elliot Parks, President & CEO, Hawaii Biotech

D. Elliot Parks, Ph.D., is President and CEO of Hawaii Biotech Inc.  Hawaii Biotech is developing a pipeline of vaccines for emerging and re-emerging infectious diseases, including neuro-invasive and hemorrhagic viruses.  The company has initiated clinical studies with two recombinant subunit protein vaccines, against dengue and West Nile virus.  Hawaii Biotech is also developing small molecule anti-toxin drugs for biodefense threats, including anthrax and botulism.  Dr. Parks has served in key leadership positions in academic research at The Scripps Research Institute, in technology acquisition and product development at Johnson & Johnson, in development and commercialization as CEO at Hawaii Biotech and Myelos Neurosciences, and as fund manager at Hamilton BioVentures and Ventana Capital Management.  He holds more than a dozen US patents.

back to speakers